Cancer Metabolomics Approaches
Metabolomics cancer research is being used to discover diagnostic cancer biomarkers in the clinic and in a research institute, to a better understand its complex heterogeneous nature, to discover pathways which involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide evidence to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate aims of most metabolomics cancer studies are to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient. Untargeted metabolomics is an important and excellent tool for probing cancer-altered biochemical pathways.
Related Conference of Cancer Metabolomics Approaches
20th International Conference on Metabolomics & Systems Biology
16th International Conference on Tissue Science and Regenerative Medicine
Cancer Metabolomics Approaches Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Regenerative Medicine Market - Tissue Science 2024 (Italy)
- .Bone Tissue Engineering - Tissue Science 2024 (Italy)
- Anti-Aging, Regenerative and functional Medicine - Tissue Science 2024 (Italy)
- Applications of Tissue Engineering - Tissue Science 2024 (Italy)
- Artificial Organs - Tissue Science 2024 (Italy)
- Bio Banking - Tissue Science 2024 (Italy)
- Biochemistry - Glycobiology 2024 (Canada)
- Biofabrication and 3D Printing - Tissue Science 2024 (Italy)
- Biomaterials and Bioengineering - Tissue Science 2024 (Italy)
- Biomedical Engineering Techniques - Tissue Science 2024 (Italy)
- Biosimilar Interchangeability - BIOSIMILARS 2024 (UK)
- Biosimilar Pharmacovigilance - BIOSIMILARS 2024 (UK)
- Biosimilars and Health Economics - BIOSIMILARS 2024 (UK)
- Biosimilars for Rare Diseases - BIOSIMILARS 2024 (UK)
- Biosimilars in Oncology - BIOSIMILARS 2024 (UK)
- Biotechnology and nanotechnology in stem cells - Tissue Science 2024 (Italy)
- Cardiovascular Regeneration: - Tissue Science 2024 (Italy)
- Cell and Organ Regeneration - Tissue Science 2024 (Italy)
- Cellular and gene Therapies - Tissue Science 2024 (Italy)
- Clinical Applications and Translational Research: - Tissue Science 2024 (Italy)
- Clinical Trials and Comparative Studies - BIOSIMILARS 2024 (UK)
- Dental and Craniofacial Regeneration: - Tissue Science 2024 (Italy)
- Emerging Technologies and Future Trends - Tissue Science 2024 (Italy)
- Evolution of Glycan Diversity - Glycobiology 2024 (Canada)
- Gene and Immunotherapy - Tissue Science 2024 (Italy)
- Global Perspectives and Healthcare Equity: - Tissue Science 2024 (Italy)
- Glycan’s - Glycobiology 2024 (Canada)
- Glycans in Drug Design - Glycobiology 2024 (Canada)
- Glycobiology - Glycobiology 2024 (Canada)
- Glycochemistry - Glycobiology 2024 (Canada)
- Glycoimmunology - Glycobiology 2024 (Canada)
- Glycoinformatics - Glycobiology 2024 (Canada)
- Glyconeurobiology - Glycobiology 2024 (Canada)
- Glycopathology - Glycobiology 2024 (Canada)
- Glycoscience - Glycobiology 2024 (Canada)
- Immunomodulation and Tissue Compatibility - Tissue Science 2024 (Italy)
- Musculoskeletal Regeneration: - Tissue Science 2024 (Italy)
- Neuro regeneration and Brain Repair: - Tissue Science 2024 (Italy)
- Pediatric Clinical Trials for Biosimilars - BIOSIMILARS 2024 (UK)
- Regenerative Rehabilitation - Tissue Science 2024 (Italy)
- Soft Tissue Replacement - Tissue Science 2024 (Italy)
- Stem Cell Bioprocessing - Tissue Science 2024 (Italy)
- Stem Cell Treatments - Tissue Science 2024 (Italy)
- Stem Cells and Regenerative Therapies: - Tissue Science 2024 (Italy)
- Synthesis and Biological Role of Glycans - Glycobiology 2024 (Canada)
- Tissue Engineering - Tissue Science 2024 (Italy)
- Tissue Engineering and Biomaterials - Tissue Science 2024 (Italy)
- Tissue Repair and Regeneration - Tissue Science 2024 (Italy)
- Workshops and Interactive Sessions: - Tissue Science 2024 (Italy)